A deficiency can manifest as dryness, acne, or even hyperpigmentation
Lilly announced a new agreement with the Trump administration to expand access to its GLP-1 therapies, including Zepbound and orforglipron, offering the drugs to Medicare beneficiaries for $50 per month and through Medicaid programs starting in 2026
For broader stacking context, see the PepPal peptide stacking guide
Millions of Americans rely on GLP-1 drugs to improve their health, but bad actors are peddling dangerous fakes, said AG Skrmetti
Because visceral fat is closely tied to insulin resistance, inflammation, stress hormones, sleep quality, and overall metabolic health, targeted changes in these areas can lead to meaningful improvement over time
Scientists have explored different theories, but the most compelling include: 1